A Study of Saquinavir Used Alone or in Combination With Other Anti-HIV Drugs in HIV-Infected Patients
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
To offer an investigational agent (saquinavir) to people with HIV/AIDS who are in need of
additional treatment options and are not eligible to enroll in ongoing clinical trials.
Patients who no longer benefit from existing antiretroviral therapy and who are not currently
enrolled in ongoing saquinavir trials are eligible for this compassionate treatment program.